NEW COAS IN ONCOLOGY GUIDE
QM COAs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using COA measures in a free oncology-focused guide.
Read the Guide
QualityMetric is sharing new insights surrounding its SF-6Dv2 Health Utility Survey at an upcoming conference hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
On Tuesday, November 8th, at ISPOR Europe 2022 in Vienna, Austria, QM statistician Regina Rendas-Baum will offer insight on the development of the SF-6Dv2, a unique patient-reported outcomes (PRO) instrument used by many professionals in the clinical research space to capture health utility and inform product lifecycles. Data presented is obtained with support from QM’s science team, which includes Senior Scientist and Associate Director of Quantitative Research Kristen McCausland, PhD, MPH, and Chief Science Officer Jakob Bjorner, MD, PhD.
Don’t miss the informative session for both in-person and virtual event attendees.
In-Person and Virtual Poster Session 3
Acceptance Code HTA163
Presented by Regina Rendas-Baum, Statistician
Tuesday, November 8th, 2022
10:00–13:15 CET
View the full poster session abstract.
The International Society for Pharmacoeconomics and Outcomes Research is the leading professional society for health economics and outcomes research (HEOR) dedicated to improving global health decision-making. This year’s Europe conference takes place November 6–9, 2022, virtually and in person at the Austria Center Vienna.